# Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal Cancer

> **NCT07645118** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Dr. Te Vuong** · enrollment: 10 (estimated)

## Conditions studied

- Locally Advanced Rectal Cancer

## Interventions

- **DRUG:** Nivolumab
- **DEVICE:** HDRBET
- **PROCEDURE:** Total Mesorectal Excision (TME)

## Key facts

- **NCT ID:** NCT07645118
- **Lead sponsor:** Dr. Te Vuong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2028-12
- **Final completion:** 2030-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07645118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07645118, "Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07645118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*